{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:50:22Z","timestamp":1770835822302,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701615"],"award-info":[{"award-number":["81701615"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91542121,81571603"],"award-info":[{"award-number":["91542121,81571603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Capital Foundation of Medical Developments","award":["2016-2-4063"],"award-info":[{"award-number":["2016-2-4063"]}]},{"name":"the Science and Technology Commission Foundation of Beijing","award":["Z151100004015143, Z171100001017208"],"award-info":[{"award-number":["Z151100004015143, Z171100001017208"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10067-018-4031-4","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T22:22:16Z","timestamp":1521066136000},"page":"1573-1580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy"],"prefix":"10.1007","volume":"37","author":[{"given":"Ya-Mei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Lin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"4031_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10067-015-2891-4","volume":"34","author":"J Jones","year":"2015","unstructured":"Jones J, Wortmann R (2015) Idiopathic inflammatory myopathies-a review. Clin Rheumatol 34:839\u2013844. \n                    https:\/\/doi.org\/10.1007\/s10067-015-2891-4","journal-title":"Clin Rheumatol"},{"key":"4031_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cca.2015.02.007","volume":"444","author":"X Lu","year":"2015","unstructured":"Lu X, Peng Q, Wang G (2015) Discovery of new biomarkers of idiopathic inflammatory myopathy. Clin Chim Acta 444:117\u2013125. \n                    https:\/\/doi.org\/10.1016\/j.cca.2015.02.007","journal-title":"Clin Chim Acta"},{"key":"4031_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/BOR.0b013e328313bff4","volume":"20","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ (2008) Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol 20:675\u2013680. \n                    https:\/\/doi.org\/10.1097\/BOR.0b013e328313bff4","journal-title":"Curr Opin Rheumatol"},{"key":"4031_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/annrheumdis-2015-207509","volume":"75","author":"DF Fiorentino","year":"2016","unstructured":"Fiorentino DF, Presby M, Baer AN, Petri M, Rieger KE, Soloski M, Rosen A, Mammen AL, Christopher-Stine L, Casciola-Rosen L (2016) PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjogren's syndrome. Ann Rheum Dis 75:1145\u20131151. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2015-207509","journal-title":"Ann Rheum Dis"},{"key":"4031_CR5","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1172\/JCI81031","volume":"125","author":"I Albrecht","year":"2015","unstructured":"Albrecht I, Wick C, Hallgren A, Tjarnlund A, Nagaraju K, Andrade F, Thompson K, Coley W, Phadke A, Diaz-Gallo LM et al (2015) Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. J Clin Invest 125:4612\u20134624. \n                    https:\/\/doi.org\/10.1172\/jci81031","journal-title":"J Clin Invest"},{"key":"4031_CR6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1074\/jbc.M805395200","volume":"284","author":"L Corsini","year":"2009","unstructured":"Corsini L, Hothorn M, Stier G, Rybin V, Scheffzek K, Gibson TJ, Sattler M (2009) Dimerization and protein binding specificity of the U2AF homology motif of the splicing factor Puf60. J Biol Chem 284:630\u2013639. \n                    https:\/\/doi.org\/10.1074\/jbc.M805395200","journal-title":"J Biol Chem"},{"key":"4031_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1469-8","volume":"19","author":"H Yang","year":"2017","unstructured":"Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, Lu X, Shu X, Zhang S, Wang G (2017) Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19:259. \n                    https:\/\/doi.org\/10.1186\/s13075-017-1469-8","journal-title":"Arthritis Res Ther"},{"key":"4031_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347. \n                    https:\/\/doi.org\/10.1056\/nejm197502132920706","journal-title":"N Engl J Med"},{"key":"4031_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337\u2013345. \n                    https:\/\/doi.org\/10.1016\/j.nmd.2004.02.006","journal-title":"Neuromuscul Disord"},{"key":"4031_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/00002281-199911000-00004","volume":"11","author":"Y Ioannou","year":"1999","unstructured":"Ioannou Y, Sultan S, Isenberg DA (1999) Myositis overlap syndromes. Curr Opin Rheumatol 11:468\u2013474","journal-title":"Curr Opin Rheumatol"},{"key":"4031_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0465-0","volume":"16","author":"EE Bailey","year":"2014","unstructured":"Bailey EE, Fiorentino DF (2014) Amyopathic dermatomyositis: definitions, diagnosis, and management. Curr Rheumatol Rep 16:465. \n                    https:\/\/doi.org\/10.1007\/s11926-014-0465-0","journal-title":"Curr Rheumatol Rep"},{"key":"4031_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F, International Myositis and Clinical Studies Group (IMACS) (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43:49\u201354. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/keg427","journal-title":"Rheumatology (Oxford)"},{"key":"4031_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141616","volume":"10","author":"Y Ge","year":"2015","unstructured":"Ge Y, Lu X, Peng Q, Shu X, Wang G (2015) Clinical characteristics of Anti-3-Hydroxy-3-Methylglutaryl coenzyme a Reductase antibodies in Chinese patients with idiopathic inflammatory myopathies. PLoS One 10:e0141616. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0141616","journal-title":"PLoS One"},{"key":"4031_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12104-008-9123-7","volume":"2","author":"L Corsini","year":"2008","unstructured":"Corsini L, Sattler M (2008) Backbone assignment of the UHM domain of Puf60 free and bound to five ligands. Biomol NMR Assign 2:211\u2013214. \n                    https:\/\/doi.org\/10.1007\/s12104-008-9123-7","journal-title":"Biomol NMR Assign"},{"key":"4031_CR15","doi-asserted-by":"publisher","first-page":"82493","DOI":"10.18632\/oncotarget.12696","volume":"7","author":"S Kobayashi","year":"2016","unstructured":"Kobayashi S, Hoshino T, Hiwasa T, Satoh M, Rahmutulla B, Tsuchida S, Komukai Y, Tanaka T, Matsubara H, Shimada H, Nomura F, Matsushita K (2016) Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients. Oncotarget 7:82493\u201382503. \n                    https:\/\/doi.org\/10.18632\/oncotarget.12696","journal-title":"Oncotarget"},{"key":"4031_CR16","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1158\/0008-5472.CAN-04-4459","volume":"66","author":"K Matsushita","year":"2006","unstructured":"Matsushita K, Tomonaga T, Shimada H, Shioya A, Higashi M, Matsubara H, Harigaya K, Nomura F, Libutti D, Levens D, Ochiai T (2006) An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis. Cancer Res 66:1409\u20131417. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-04-4459","journal-title":"Cancer Res"},{"key":"4031_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-015-8496-5","volume":"51","author":"Y Muro","year":"2016","unstructured":"Muro Y, Sugiura K, Akiyama M (2016) Cutaneous manifestations in Dermatomyositis: key clinical and serological features-a comprehensive review. Clin Rev Allergy Immunol 51:293\u2013302. \n                    https:\/\/doi.org\/10.1007\/s12016-015-8496-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"4031_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/acr.22498","volume":"67","author":"NS Narang","year":"2015","unstructured":"Narang NS, Casciola-Rosen L, Li S, Chung L, Fiorentino DF (2015) Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care Res (Hoboken) 67:667\u2013672. \n                    https:\/\/doi.org\/10.1002\/acr.22498","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4031_CR19","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1002\/art.34657","volume":"64","author":"T Gono","year":"2012","unstructured":"Gono T, Kawaguchi Y, Kuwana M, Sugiura T, Furuya T, Takagi K, Ichida H, Katsumata Y, Hanaoka M, Ota Y, Yamanaka H (2012) Brief report: association of HLA-DRB1*0101\/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheum 64:3736\u20133740. \n                    https:\/\/doi.org\/10.1002\/art.34657","journal-title":"Arthritis Rheum"},{"key":"4031_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/01.bor.0000434676.70268.66","volume":"25","author":"S Rothwell","year":"2013","unstructured":"Rothwell S, Cooper RG, Lamb JA, Chinoy H (2013) Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol 25:735\u2013741. \n                    https:\/\/doi.org\/10.1097\/01.bor.0000434676.70268.66","journal-title":"Curr Opin Rheumatol"},{"key":"4031_CR21","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/art.22205","volume":"54","author":"TP O'Hanlon","year":"2006","unstructured":"O'Hanlon TP, Rider LG, Mamyrova G, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Chanock SJ, Foster CB, Bunch T, Reed AM, Love LA, Miller FW (2006) HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 54:3670\u20133681. \n                    https:\/\/doi.org\/10.1002\/art.22205","journal-title":"Arthritis Rheum"},{"key":"4031_CR22","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/rheumatology\/kep248","volume":"48","author":"H Chinoy","year":"2009","unstructured":"Chinoy H, Payne D, Poulton KV, Fertig N, Betteridge Z, Gunawardena H, Davidson JE, Oddis CV, McHugh NJ, Wedderburn LR et al (2009) HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology (Oxford) 48:1213\u20131217. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kep248","journal-title":"Rheumatology (Oxford)"},{"key":"4031_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.berh.2016.04.007","volume":"30","author":"J Tieu","year":"2016","unstructured":"Tieu J, Lundberg IE, Limaye V (2016) Idiopathic inflammatory myositis. Best Pract Res Clin Rheumatol 30:149\u2013168. \n                    https:\/\/doi.org\/10.1016\/j.berh.2016.04.007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4031_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","volume":"5","author":"A Ghirardello","year":"2014","unstructured":"Ghirardello A, Borella E, Beggio M, Franceschini F, Fredi M, Doria A (2014) Myositis autoantibodies and clinical phenotypes. Auto Immun Highlights 5:69\u201375. \n                    https:\/\/doi.org\/10.1007\/s13317-014-0060-4","journal-title":"Auto Immun Highlights"},{"key":"4031_CR25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jbspin.2006.04.005","volume":"73","author":"C Sordet","year":"2006","unstructured":"Sordet C, Goetz J, Sibilia J (2006) Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 73:646\u2013654. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2006.04.005","journal-title":"Joint Bone Spine"},{"key":"4031_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.autrev.2010.05.020","volume":"9","author":"C Belizna","year":"2010","unstructured":"Belizna C, Henrion D, Beucher A, Lavigne C, Ghaali A, Levesque H (2010) Anti-Ku antibodies: clinical, genetic and diagnostic insights. Autoimmun Rev 9:691\u2013694. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2010.05.020","journal-title":"Autoimmun Rev"},{"key":"4031_CR27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","volume":"6","author":"M Mahler","year":"2007","unstructured":"Mahler M, Raijmakers R (2007) Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights. Autoimmun Rev 6:432\u2013437. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2007.01.013","journal-title":"Autoimmun Rev"},{"key":"4031_CR28","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1002\/art.22865","volume":"56","author":"KB Stone","year":"2007","unstructured":"Stone KB, Oddis CV, Fertig N, Katsumata Y, Lucas M, Vogt M, Domsic R, Ascherman DP (2007) Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum 56:3125\u20133131. \n                    https:\/\/doi.org\/10.1002\/art.22865","journal-title":"Arthritis Rheum"},{"key":"4031_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","volume":"23","author":"S Sato","year":"2013","unstructured":"Sato S, Kuwana M, Fujita T, Suzuki Y (2013) Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23:496\u2013502. \n                    https:\/\/doi.org\/10.1007\/s10165-012-0663-4","journal-title":"Mod Rheumatol"},{"key":"4031_CR30","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/rheumatology\/keu436","volume":"54","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C, Qi Z, Koontz D, Levesque MC (2015) Anti-signal recognition particle autoantibody ELISA validation and clinical associations. Rheumatology (Oxford) 54:1194\u20131199. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/keu436","journal-title":"Rheumatology (Oxford)"},{"key":"4031_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00240-6","volume":"7","author":"Y Ge","year":"2017","unstructured":"Ge Y, Lu X, Shu X, Peng Q, Wang G (2017) Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts. Sci Rep 7:188. \n                    https:\/\/doi.org\/10.1038\/s41598-017-00240-6","journal-title":"Sci Rep"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4031-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4031-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4031-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T20:45:55Z","timestamp":1552596355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4031-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4031"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4031-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"26 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Institutional Review Board at the China-Japan Friendship Hospital (reference number: 2016-117). All the participants provided written informed consent for the collection of samples and subsequent analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}